| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $656.1M | +15.4% |
| Cost of Revenue | $481.4M | +14.2% |
| Gross Profit | $174.7M | +19.0% |
| R&D Expense | $7.7M | -8.3% |
| SG&A Expense | $94.9M | +3.5% |
| Operating Income | $73.6M | -17.0% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | $61.5M | -16.8% |
| Income Tax | $14.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $97.6M | +11.6% |
| Inventory | $149.7M | +9.2% |
| Current Assets | $266.0M | +11.7% |
| Total Assets | $626.7M | +6.2% |
| Current Liabilities | $95.8M | +36.5% |
| Long-term Debt | $144.0M | -2.4% |
| Stockholders' Equity | $281.4M | +6.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $74.7M | +81.6% |
| Capital Expenditures | $10.8M | +39.5% |
| Investing Cash Flow | -$37.5M | -166.0% |
| Financing Cash Flow | -$34.1M | +70.9% |
| Free Cash Flow | $63.9M | +91.4% |
| -17.6% |
| Net Income | $46.9M | -16.5% |
| EPS (Basic) | $1.99 | -16.7% |
| EPS (Diluted) | $1.96 | -16.9% |